Related Experiment Video

Updated: Apr 25, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

10.9K

Rotavirus vaccine: a review

Goel Manish Kumar, Kumar Arun, Jain Ram Bilas

    The Journal of Communicable Diseases
    |August 23, 2014
    PubMed

    Insights

    Rotavirus vaccines are crucial for preventing childhood diarrhea deaths, showing good efficacy and safety. Current World Health Organization (WHO) guidelines recommend specific age windows for administration without booster doses.

    Area of Science:

    • Pediatric Infectious Diseases
    • Vaccinology
    • Public Health

    Background:

    • Rotavirus accounts for 37% of global childhood diarrhea deaths.
    • Existing rotavirus vaccines (monovalent, pentavalent) demonstrate clinical efficacy and safety, with no increased intussusception risk.
    • The World Health Organization (WHO) provides recommendations for rotavirus vaccine administration.

    Purpose of the Study:

    • To review milestones in rotavirus vaccine development.
    • To discuss efficacy, cost-effectiveness, and post-marketing surveillance of rotavirus vaccines.
    • To outline current WHO recommendations and future research directions for rotavirus vaccines.

    Main Methods:

    • Literature review of rotavirus vaccine development and usage.
    • Analysis of clinical efficacy and safety data.
    • Examination of World Health Organization (WHO) recommendations and surveillance data.

    Main Results:

    • Rotavirus vaccines have shown good clinical efficacy without increasing intussusception.
    • WHO recommends specific age ranges for the first and last doses (6-15 weeks and 32 weeks, respectively).
    • Booster doses are not recommended.

    Conclusions:

    • Rotavirus vaccines are effective tools for reducing childhood mortality from diarrhea.
    • Ongoing surveillance and research are essential to address challenges like viral strain evolution and cost-effectiveness.
    • Adherence to WHO vaccination schedules is critical for optimal public health impact.

    More Related Videos

    Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins11:40

    Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

    Published on: April 17, 2020

    8.6K
    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay09:14

    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

    Published on: January 26, 2019

    10.6K

    Related Concept Videos

    Bacterial Gastroenteritis01:18

    Bacterial Gastroenteritis

    Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
    83
    Vaccines01:21

    Vaccines

    Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
    86
    Vaccinations01:51

    Vaccinations

    Overview
    43.8K
    Vaccine Production01:23

    Vaccine Production

    Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
    129
    Rous Sarcoma Virus (RSV) and Cancer01:03

    Rous Sarcoma Virus (RSV) and Cancer

    Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
    RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
    5.2K
    Rous Sarcoma Virus (RSV) and Cancer01:03

    Rous Sarcoma Virus (RSV) and Cancer

    4.9K